Eloxx Pharmaceuticals appoints Geno J. Germano to board

ELOX•2026-10-22

Eloxx Pharmaceuticals appointed Geno J. Germano to its board on October 19, 2026, expanding the board from five directors to six.

1. Board appointment

Germano's term expires at the 2027 annual shareholder meeting. He served as president and CEO of Elucida Oncology from August 2018 to June 2024, after holding senior roles at Pfizer.

Sources

Eloxx Pharmaceuticals appoints Geno J. Germano to board

Sec

Eloxx Pharmaceuticals appoints Geno J. Germano to board

1. Board appointment

Related News

CME Group target price raised to $321 from $281 by Barclays

Old National Bancorp: TD Cowen cuts target price to $29 from $30

Varex Imaging faces two shareholder lawsuits over merger disclosures

Sources

Eloxx Pharmaceuticals appoints Geno J. Germano to board

Citigroup raises Hasbro target price to $137 from $117

Morgan Stanley raises Tesla target price to $410 from $400